Aug. 24, 2026 — The VIVA Foundation will spotlight the latest advances in vascular medicine as 26 clinical trials are presented during The VEINS and VIVA 2026, taking place Oct. 3-6, at Bellagio Las ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
Aug. 29, 2026— Vesalio recently announced results from the NATURE trial (NCT04969471), a prospective, randomized ...
Sept. 8, 2026 — New research1 indicates that people with invasive cancer face an elevated risk of experiencing a stroke ...
Aug. 31, 2026 — Amgen has announced new findings showing Repatha (evolocumab) reduced the risk of death in high-risk ...
Aug. 31, 2026 — At the European Society of Cardiology Congress in Munich, Abbott announced new late-breaking 12-month ...
Aug. 26, 2026 – The Cardiovascular Research Foundation (CRF) announced the late-breaking clinical trials and science sel ...
Aug. 21, 2026 — Milestone Pharmaceuticals Inc. has announced that the first patient has been enrolled in the Phase 3 ...
Aug. 24, 2026 — The VIVA Foundation will spotlight the latest advances in vascular medicine as 26 clinical trials are ...
Aug. 20, 2026 — A new study found that nearly 8 out of 10 young adult participants, average age 23 years, had cardiovasc ...
Aug. 13, 2026 — Researchers from the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the ...
Aug. 4, 2026 — Abbott has completed enrollment in its TECTONIC coronary artery disease (CAD) Intravascular Lithotripsy ...
July 23, 2026 — The results of 59 ground-breaking trials will be unveiled for the first time at ESC Congress 2026, the ...
July 21, 2026 — Women who experience pregnancy complications face an increased risk of developing peripheral artery ...
July 20, 2026 — Young women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovarian ...
July 9, 2026 — A new artificial intelligence (AI) clinical tool developed by researchers at the University of Maryland ...
June 25, 2026 — Johnson & Johnson has announced the initiation of its Skyward investigational device exemption (IDE) ...
September 10, 2026